EDGAR Filing Documents for 0001654954-18-001133

Form D - Notice of Exempt Offering of Securities:

SEC Accession No. 0001654954-18-001133

Filing Date

2018-02-06

Accepted

2018-02-06 17:29:57

Documents

Effectiveness Date

2018-02-06

Items

Item 06b:

Document Format Files

Seq	Description	Document	Type	Size
1		primary_doc.html	D
1		primary_doc.xml	D	6865
	Complete submission text file	0001654954-18-001133.txt		8299

Mailing Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602

Business Address 1825 K STREET SUITE 510 WASHINGTON, D.C. DC 33602 (800) 304-9888

GT Biopharma, Inc. (Filer) CIK: 0000109657 (see all company filings)